Jennifer B. Raftis
Edinburgh, SCT, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Impact of local and national policies to reduce agriculture-related air pollution through improving diet and farm management: the AMPHoRA mixed methods study.
Journal: Public health research (Southampton, England)
Published: March 09, 2026
PAR4 Antagonism in Patients With Coronary Artery Disease Receiving Antiplatelet Therapies.
Journal: Arteriosclerosis, thrombosis, and vascular biology
Published: February 15, 2024
First-in-human controlled inhalation of thin graphene oxide nanosheets to study acute cardiorespiratory responses.
Journal: Nature nanotechnology
Published: February 11, 2023
18F-GP1 Positron Emission Tomography and Bioprosthetic Aortic Valve Thrombus.
Journal: JACC. Cardiovascular imaging
Published: July 20, 2021
Antithrombotic Effects of Combined PAR (Protease-Activated Receptor)-4 Antagonism and Factor Xa Inhibition.
Journal: Arteriosclerosis, thrombosis, and vascular biology
Published: September 10, 2020
Acute cardiovascular effects of controlled exposure to dilute Petrodiesel and biodiesel exhaust in healthy volunteers: a crossover study.
Journal: Particle and fibre toxicology
Published: June 10, 2020
Assessment of the physicochemical properties of chrysotile-containing brake debris pertaining to toxicity.
Journal: Inhalation toxicology
Published: November 07, 2019
Nanoparticle translocation and multi-organ toxicity: A particularly small problem.
Journal: Nano today
Published: June 21, 2019
Ticagrelor to Reduce Myocardial Injury in Patients With High-Risk Coronary Artery Plaque.
Journal: JACC. Cardiovascular imaging
Published: March 20, 2019
Correction to"Inhaled Nanoparticles Accumulate at Sites of Vascular Disease".
Journal: ACS nano
Published: October 05, 2017
PAR4 (Protease-Activated Receptor 4) Antagonism With BMS-986120 Inhibits Human Ex Vivo Thrombus Formation.
Journal: Arteriosclerosis, thrombosis, and vascular biology
Published: August 11, 2017
Inhaled Nanoparticles Accumulate at Sites of Vascular Disease.
Journal: ACS nano
Published: April 27, 2017
Last Updated: 09/26/2026